Paper
0
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
Authors
David Cameron,Michelle Casey
Michael Press,Deborah Lindquist,Tadeusz Pieńkowski,C Romieu,Stephen Chan,Agnieszka Jagiełło-Gruszfeld,Bella Kaufman,John Crown,Arlene Chan,Mario Campone,Patrice Viens,N. Davidson,Vera Gorbounova,Johannes Raats,Dimosthenis Skarlos,B. Newstat,Debasish Roychowdhury,Paolo Paoletti,Cristina Oliva,Stephen Rubin,Steven Stein,Charles Geyer
+22 authors
,Sy ChanPublished
Jan 10, 2008
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.